Get the Stockscreener App
2.98
3.11%
0.09
After Hours:
3.04
0.06
+2.01%
Absci Corp stock is traded at $2.98, with a volume of 2.19M.
It is up +3.11% in the last 24 hours and down -16.53% over the past month.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
See More
Previous Close:
$2.89
Open:
$2.9
24h Volume:
2.19M
Relative Volume:
0.55
Market Cap:
$448.11M
Revenue:
$4.21M
Net Income/Loss:
$-97.67M
P/E Ratio:
-3.2043
EPS:
-0.93
Net Cash Flow:
$-70.76M
1W Performance:
+2.76%
1M Performance:
-16.53%
6M Performance:
+3.11%
1Y Performance:
-21.78%
1-Day Range:
$2.87
$2.99
1-Week Range:
$2.87
$3.195
52-Week Range:
$2.01
$6.33
Absci Corp Stock (ABSI) Company Profile
Name
Absci Corp
Sector
Industry
Phone
(360) 949-1041
Address
18105 SE MILL PLAIN BLVD, VANCOUVER
Compare ABSI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
2.98 | 434.57M | 4.21M | -97.67M | -70.76M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-26 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-02-25 | Initiated | JP Morgan | Overweight |
| Jul-03-25 | Resumed | Morgan Stanley | Overweight |
| Jan-22-25 | Initiated | Needham | Buy |
| Oct-02-24 | Initiated | Guggenheim | Buy |
| Jul-03-24 | Initiated | Morgan Stanley | Overweight |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-04-23 | Initiated | H.C. Wainwright | Buy |
| Aug-12-22 | Downgrade | JP Morgan | Overweight → Underweight |
| Jul-18-22 | Initiated | Truist | Buy |
| Mar-02-22 | Resumed | Cowen | Market Perform |
| Feb-01-22 | Initiated | Berenberg | Buy |
| Nov-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Aug-16-21 | Initiated | BofA Securities | Neutral |
| Aug-16-21 | Initiated | Cowen | Market Perform |
| Aug-16-21 | Initiated | Credit Suisse | Outperform |
| Aug-16-21 | Initiated | Stifel | Hold |
View All
Absci Corp Stock (ABSI) Latest News
Absci Corporation (NASDAQ:ABSI) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Absci Corporation's (NASDAQ:ABSI) recent 12% pullback adds to one-year year losses, institutional owners may take drastic measures - Yahoo Finance
Sentiment Review: Is Charter Communications Inc stock a buy or sellBull Run & AI Forecasted Entry/Exit Points - baoquankhu1.vn
EPS Watch: Can Absci Corporation lead its sector in growth2025 Volatility Report & Safe Capital Allocation Plans - baoquankhu1.vn
H.B. Fuller, Caledonia Mining And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Absci Unveils Origin-1 AI Model, Teases 2025 Hair-Loss Data and Q4 Endometriosis Trial Launch - Yahoo Finance
Absci Corp Presents Business Update at J.P. Morgan Healthcare Conference - TradingView
Analysts Cut Absci (ABSI) Target, Spotlight New Alopecia Therapy in Early Trials - Finviz
10 Best Penny Stocks to Buy for 2026 - Insider Monkey
JonesTrading Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $9 - 富途牛牛
Absci (NASDAQ:ABSI) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
How Absci Corporation stock benefits from global expansionEarnings Trend Report & Real-Time Market Trend Scan - ulpravda.ru
Will Absci Corporation stock benefit from commodity pricesJuly 2025 Weekly Recap & Real-Time Buy Signal Notifications - Улправда
What dividend safety score for Absci Corporation stockMarket Trend Review & Target Return Focused Picks - Улправда
Published on: 2026-01-08 23:53:06 - ulpravda.ru
Absci (NASDAQ:ABSI) Shares Down 9.1%Here's What Happened - MarketBeat
Morgan Stanley downgrades Absci stock on TL1A setback and higher risk profile - Investing.com Nigeria
Morgan Stanley Downgrades Absci Corp(ABSI.US) to Hold Rating, Cuts Target Price to $4.32 - 富途牛牛
How resilient is Absci Corporation stock in market downturnsEarnings Miss & AI Optimized Trade Strategies - moha.gov.vn
Absci Corporation (ABSI) Reports Q2 Loss, Misses Revenue Estimates - MSN
Absci Corporation (NASDAQ:ABSI) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Absci Corp | 4: Statement of changes in beneficial ownership of securities-Director VAN HOUTEN FRANS - 富途牛牛
Absci Corporation (ABSI) Investor Outlook: Unpacking a 136% Potential Upside in Biotech Innovation - DirectorsTalk Interviews
Absci Unveils Preclinical Data for AI-Designed ABS-201, Targeting a Novel Hormonal Pathway for Hair Loss Treatment - Finviz
Absci Corporation (ABSI) Announces First Participants Dosed In Phase 1/2a HEADLINE Trial - Finviz
Morgan Stanley Assumes Coverage on Absci Corporation (ABSI) with $7 Target - MSN
10 Best Biotech Penny Stocks to Buy According to Analysts - Insider Monkey
Absci Corporation (ABSI) Draws Full Buy Consensus With 150% Upside Potential - Finviz
Absci (NASDAQ:ABSI) Trading Down 4.2%Here's What Happened - MarketBeat
Absci (NASDAQ:ABSI) Trading Up 11.1%Time to Buy? - MarketBeat
Why analysts remain bullish on Absci Corporation stockWeekly Profit Analysis & Smart Investment Allocation Tips - Улправда
Will Absci Corporation stock recover faster than peersMarket Risk Summary & Reliable Entry Point Alerts - Улправда
What technical charts say about Absci Corporation stock2025 Pullback Review & Weekly Chart Analysis and Trade Guides - Улправда
Is Absci Corporation stock a defensive play in 2025CPI Data & Risk Controlled Stock Pick Alerts - Улправда
Will Absci Corporation stock keep outperforming rivalsPortfolio Update Summary & Weekly Sector Rotation Insights - Улправда
ABSI Stock: HC Wainwright & Co. Raises Price Target to $8.00 | A - GuruFocus
Absci Corporation (NASDAQ:ABSI)’s ABS‑201 Shows Promise in Hair Loss Treatment, Analysts See Upside - Insider Monkey
H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Raises Target Price to $8 - 富途牛牛
14 Best Multibagger Penny Stocks to Buy Right Now - Insider Monkey
Will ABS-201 From Absci Transform The Future Of Hair Regeneration? - RTTNews
Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Needham Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $7 - 富途牛牛
Absci (NASDAQ:ABSI) Receives "Buy" Rating from Needham & Company LLC - MarketBeat
Truist Financial Maintains Absci Corp(ABSI.US) With Buy Rating - 富途牛牛
Absci Corp Stock (ABSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.09%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):